Bayer CropScience (BOM:506285) Cyclically Adjusted Revenue per Share: ₹1,246.06 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:506285 Bayer CropScience Ltd BOM:506285
79 GF Score
Price ₹4,105.70
GF Value ₹5,807.57
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Bayer CropScience Cyclically Adjusted Revenue per Share?

Bayer CropScience BOM:506285 +0.11% 79 Cyclically Adjusted Revenue per Share is ₹1,246.06 as of Jun. 2026. GuruFocus rates BOM:506285 with a GF Score™ of 79/100 and a GF Value™ of ₹5,807.57 (Modestly Undervalued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bayer CropScience's adjusted revenue per share for the three months ended in Jun. 2026 was ₹408.313. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹1,246.06 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Bayer CropScience's average Cyclically Adjusted Revenue Growth Rate was 4.10% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 2.10% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 3.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bayer CropScience was 5.00% per year. The lowest was 2.10% per year. And the median was 4.10% per year.

As of today (2026-08-19), Bayer CropScience's current stock price is ₹4105.70. Bayer CropScience's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹1,246.06. Bayer CropScience's Cyclically Adjusted PS Ratio of today is 3.29.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer CropScience was 6.25. The lowest was 3.03. And the median was 4.42.


Bayer CropScience  (BOM:506285) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer CropScience's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=4105.70/1246.06
=3.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer CropScience was 6.25. The lowest was 3.03. And the median was 4.42.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bayer CropScience Cyclically Adjusted Revenue per Share Related Terms


Bayer CropScience Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Bayer CropScience's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bayer CropScience Cyclically Adjusted Revenue per Share Chart

Bayer CropScience Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,098.31 1,154.86 1,175.95 1,170.53 1,227.65

Bayer CropScience Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,197.28 1,207.74 1,216.13 1,227.65 1,246.06

BOM:506285 vs CTVA, CF, MOS: Cyclically Adjusted Revenue per Share Comparison

For the Agricultural Inputs subindustry, Bayer CropScience's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer CropScience Cyclically Adjusted PS Ratio vs Agriculture Industry

For the Agriculture industry and Basic Materials sector, Bayer CropScience's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer CropScience's Cyclically Adjusted PS Ratio falls into.


BOM:506285
79GF Score
Bayer CropScience Ltd BOM:506285
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bayer CropScience Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer CropScience's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=408.313/167.3573*167.3573
=408.313

Current CPI (Jun. 2026) = 167.3573.

Bayer CropScience Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 312.196 105.961 493.089
201612 187.406 105.196 298.146
201703 60.893 105.196 96.875
201706 197.404 107.109 308.444
201709 349.048 109.021 535.819
201712 139.875 109.404 213.970
201803 87.499 109.786 133.383
201806 242.253 111.317 364.212
201809 359.381 115.142 522.356
201812 225.753 115.142 328.129
201903 35.029 118.202 49.596
201906 276.810 120.880 383.242
201909 392.119 123.175 532.770
201912 189.997 126.235 251.890
202003 81.954 124.705 109.984
202006 273.221 127.000 360.043
202009 307.384 130.118 395.356
202012 204.203 130.889 261.098
202103 136.869 131.771 173.833
202106 315.051 134.084 393.231
202109 303.761 135.847 374.220
202112 220.321 138.161 266.880
202203 179.241 138.822 216.085
202206 371.003 142.347 436.187
202209 323.061 144.661 373.747
202212 230.963 145.763 265.180
202303 175.263 146.865 199.718
202306 387.051 150.280 431.034
202309 359.858 151.492 397.545
202312 212.521 152.924 232.579
202403 129.136 153.035 141.222
202406 362.949 155.789 389.900
202409 386.791 157.882 410.004
202412 235.175 158.323 248.595
202503 232.792 157.552 247.280
202506 425.997 159.755 446.268
202509 345.676 162.289 356.471
202512 246.090 163.281 252.234
202603 244.949 164.272 249.549
202606 408.313 167.357 408.313

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹1,246.06 mean?
Bayer CropScience (BOM:506285) has a Cyclically Adjusted Revenue per Share of ₹1,246.06 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bayer CropScience and its competitors.
Is Bayer CropScience's Cyclically Adjusted Revenue per Share too high?
Bayer CropScience's current Cyclically Adjusted Revenue per Share is ₹1,246.06. Overall, Bayer CropScience has a GF Score™ of 79/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bayer CropScience's Cyclically Adjusted Revenue per Share compare to CTVA and CF?
Bayer CropScience's Cyclically Adjusted Revenue per Share of ₹1,246.06 can be compared against companies in the Agriculture industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for an Agriculture company?
A good Cyclically Adjusted Revenue per Share depends on the Agriculture industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Bayer CropScience and its competitors. Bayer CropScience's current Cyclically Adjusted Revenue per Share is ₹1,246.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bayer CropScience stock overvalued right now?
Based on GuruFocus' analysis, Bayer CropScience (BOM:506285) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹5,807.57, compared to a current price of ₹4,105.70 — trading 29.3% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹1,246.06. Bayer CropScience's overall GF Score™ is 79/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Bayer CropScience (BOM:506285), the current Cyclically Adjusted Revenue per Share is ₹1,246.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bayer CropScience (BOM:506285) Overvalued in 2026?

Based on GuruFocus' analysis, Bayer CropScience stock appears to be undervalued. The current stock price of ₹4,105.70 is trading 29.3% below its estimated GF Value™ of ₹5,807.57. GuruFocus considers Bayer CropScience to be Modestly Undervalued.

Key valuation signals for BOM:506285:

  • Cyclically Adjusted Revenue per Share: ₹1,246.06
  • GF Value™: ₹5,807.57 vs. price of ₹4,105.70 (29.3% below fair value)
  • GF Score™: 79/100 with 5 warning signs

No single metric tells the full story. See the BOM:506285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bayer CropScience Business Description

Other Exchanges BAYERCROP:India
Address Bayer House, Central Avenue, Bayer House, Hiranandani Estate, Thane (West), Thane, MH, IND, 400607
Bayer CropScience Ltd manufactures, distributes, and sells crop protection and hybrid seed products to the agriculture industry. The firm sells fungicides, weedicides, hybrid seeds, consumer in-home pest-control products, and other agrochemical products. Its geographical segments are India, Germany, Bangladesh, and others, of which the vast majority of its revenue comes from India. The company is a subsidiary of Bayer AG, with the majority of common shares owned by its parent company and other Bayer AG subsidiaries.
79GF Score

Get the complete analysis for BOM:506285

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹4,105.70
Price
₹5,807.57
GF Value